Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24317119.
- Also identified by DOI 10.1038/nm.3416 and PMC identifier 3886895.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this study, we monitored glycolysis in mouse lymphoma and lung tumors by measuring the conversion of hyperpolarized [U-2H, U-13C]glucose to lactate using 13C magnetic resonance spectroscopy and spectroscopic imaging. We observed labeled lactate only in tumors and not in surrounding normal tissue or other tissues in the body and found that it was markedly decreased at 24 h after treatment with a chemotherapeutic drug. We also detected an increase in a resonance assigned to 6-phosphogluconate in the pentose phosphate pathway. This technique could provide a new way of detecting early evidence of tumor treatment response in the clinic and of monitoring tumor pentose phosphate pathway activity.
Medical subject headings
- Glycolysis
- Lung Neoplasms
- Lymphoma
- Magnetic Resonance Spectroscopy